Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86,559,040
-
Total 13F shares
-
15,338,118
-
Share change
-
+253,023
-
Total reported value
-
$123,909,644
-
Put/Call ratio
-
13%
-
Price per share
-
$8.08
-
Number of holders
-
71
-
Value change
-
+$3,408,975
-
Number of buys
-
39
-
Number of sells
-
38
Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q3 2018
As of 30 Sep 2018,
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) was held by
71 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,338,118 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, MPM ASSET MANAGEMENT LLC, BlackRock Inc., BVF INC/IL, DIMENSIONAL FUND ADVISORS LP, Vanguard Group Inc, MILLENNIUM MANAGEMENT LLC, 683 Capital Management, LLC, ORBIMED ADVISORS LLC, and FMR LLC.
This page lists
72
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.